An observational study in Health Behaviors, Risk Factors and Cardiovascular Diseases, sponsored by Region Skane. Recruiting at 1 site in Sweden. Open to participants aged 40 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-10-29.
Sponsored by Region Skane · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 16 studies in Health Behavior with a site in Sweden — 6 open to participants now, 6 under way, none of them phase 3. Health Behavior · Sweden.
Among the 16 studies in Health Behavior with a site in Sweden, this one is the only one that started in 2020, is one of 5 observational ones, and was the 11th registered.
969 studies on the registry are indexed under Health Behavior; 167 are open to participants now.
Browse Health Behavior studies →6 of the 16 studies in Health Behavior with a site in Sweden are open now. Recruiting first, the newest first:
Region Stockholm · Sites in Sweden
Ages 15–80
Karolinska Institutet · Sites in Sweden
Ages 45–75
Jonkoping University · Sites in Sweden
Ages 15+ · Healthy volunteers
Population Health Research Institute · Sites in Sweden, Argentina, Bangladesh and 22 more countries
Ages 35–70
Lund University · Sites in Sweden
Ages 18–66
A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →
Of the 94 Health Behavior studies recruiting now, 40 (43%) set no upper age limit and 37 (39%) stop at 75 or younger; 25 take children under 18; 59 take healthy volunteers.
This study: 40 Years to 70 Years · all sexes.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
16 studies; the count open now beside each. This study's row is marked.
First in 2002; this study’s year is marked. 1 started in 2020.
This study's planned enrollment of 18,000 is above the median of 219 across 131 observational studies indexed under Health Behavior.
Median enrollment 160 across the 11 interventional studies, 4,000 across the 5 observational. Of the 10 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 16 has an industry lead sponsor. The 10 most frequent:
Region Skane is the lead sponsor of 386 studies on the registry; 122 are open to participants now.
Region Skane has 1 study filed under Health Behavior — fewer than ten, so there is no comparison to draw.
2 of the studies in Health Behavior with a site in Sweden that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06404632Region StockholmA Group Intervention for Promoting Health-related Habits (LEV-G) | 2027-02-28 |
| NCT05317130Lund UniversityA Complex Health Promotion Intervention in Parasport - The Safe & Healthy Parasport Project | 2027-09-01 |
Add all 2 to your calendar (.ics) → With an account.
Among the 16 studies in Health Behavior with a site in Sweden, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The County Council of Region Skåne, Sweden, has recently initiated Targeted Health Dialogues in primary care. The prevention program includes health dialogues provided by specially trained personnel, collection of clinical and laboratory data as well as questionnaire data on, e.g., individual health and health behaviors. So far, it enrolls all 40-year old Swedish and foreign-born inhabitants in the county and it will also include all 50- and 60-year old persons within a near future. A research project will be integrated within the program where the collected data will be linked, on the individual level, to national and regional data on hospital admissions, clinical diagnoses from specialist clinics and primary care, causes of death, and prescriptions. The individual linkages will also include population data on sociodemographic characteristics, neighborhood of residence and family relations. Blood samples will be collected for analyses of molecular biomarkers. The research project will examine associations between potential predictors and future risk of cardiovascular diseases and other serious diseases, such as cancer, and also whether the effect of the prevention program is modified by these potential predictors. The effect of the intervention will be examined, and whether the protocol needs to be modified in order to develop more precise and personalized medicine.
The County Council of Region Skåne, the third most populous region in Sweden with 1.4 million inhabitants, has recently initiated Targeted Health Dialogues in primary care with the ultimate goal to improve cardiovascular health in the entire population in Skåne. Targeted health dialogues have previously been proven to improve health behaviors and risk factors and decrease the incidence of cardiovascular disease and mortality. The prevention program includes, in addition to the health dialogues provided by specially trained personnel, collection of clinical and laboratory data (e.g. blood pressure, BMI, waist hip ratio, lipids, fasting blood glucose) as well as detailed questionnaire data on, e.g., individual health and symptoms, family history, diet, physical activity, alcohol and smoking. So far, it enrolls all 40-year old Swedish and foreign-born inhabitants in the county and it will also include all 50- and 60-year old persons within a near future. The County Council and the Ethical Review Board have granted permission to integrate a research project within the program where collected data will be linked, at the individual level, to national and regional data on hospital admissions, clinical diagnoses from specialist clinics and primary care, causes of death, and prescriptions. The individual linkages will also include population data on sociodemographic characteristics, neighborhood of residence and family relations. In addition to the collection and linkages of these data, blood samples will be collected for analyses of molecular biomarkers. The research project will allow for examining associations between a number of potential predictors and future risk of cardiovascular disease and other serious diseases, such as cancer, and also whether the effect of the prevention program is modified by these potential predictors. The effect of the intervention will be examined and whether the protocol needs to be modified in order to develop more precise and personalized medicine.
In Sweden, most people are listed at one healthcare center. The study population consists of all listed 40-, 50-, 60-year, and 70-year-old patients that perform a targeted health dialogue and consent to take part in the research study.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
* Inability to understand the written study information and give
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before the targeted health dialogue, the participants fill in a questionnaire about health behaviors, background characteristics and self-rated health. Samples for blood glucose and total cholesterol are taken. BMI, waist-to-hip ratio and blood pressure are measured. The results are summoned in a "health curve", which is discussed with specially trained healthcare personnel in a Targeted heath dialogue. In a sub-group, blood samples are collected for molecular analyses.
Effect of targeted health dialogues on CVD incidence
The short- and long-term effect of targeted health dialogues on incidence of CVD events, its comorbidity and CVD-related deaths in the participants compared to a general population cohort and historical controls.
Time frame: 2035
Effect of targeted health dialogues on incidence of cancer and other serious diseases
The short- and long-term effect of targeted health dialogues on incidence of cancer and other serious diseases in the participants compared to a general population cohort and historical controls.
Time frame: 2035
Modification by individual characteristics
Modification of possible associations between targeted health dialogues and future CVD, cancer, other serious diseases and preterm death by individual characteristics (e.g., sociodemographic factors)
Time frame: 2035
Association between risk factors and disease incidence
Associations between risk factors/combination of risk factors (lifestyle-related, metabolic, psychosocial and familial) at baseline and incidence of CVD, cancer, other serious diseases and preterm death.
Time frame: 2035
Identification of molecular biomarkers
The ability of biological aging, epigenetic changes and genetic and metabolomic profiles to predict CVD, cancer, other serious diseases and preterm death as well as the effect of targeted health dialogues.
Time frame: 2035
Public health profile of middle-aged citizens in Sweden's southernmost county
Level of physical activity and sedentary behavior, intake of healthy/unhealthy food, alcohol consumption, smoking habits, stress, psychological well-being, blood glucose, cholesterol, BMI, waist-hip ratio. Comparisons between subgroups: age, sex, sociodemography, previous diagnoses.
Time frame: 2035
Associations between dental and general health
Associations between dental health at baseline and incidence of CVD, cancer, other serious diseases and preterm death.
Time frame: 2035
Validation of the targeted health dialogue method
Validity and reliability of the questionnaire and targeted health dialogue method
Time frame: 2035
Health economy
Costs related to the targeted health dialogues versus individual and societal gains.
Time frame: 2035
The effect of targeted health dialogues on health behaviors and self-rated health
Time frame: 2035
Do targeted health dialogues reach all societal groups?
Time frame: 2035
Can other lifestyle interventions influence the effect of targeted health dialogues?
Time frame: 2035
Follow-up of samples taken after the targeted health dialogues.
Which samples and tests were taken as a result of the targeted health dialogues?
Time frame: 2035
Do the the targeted health dialogues influence care seeking?
Evaluation of new search patterns due to the targeted health dialogues.
Time frame: 2035
Obstacles and motivators for physical activity
What obstacles and motivators for physical activity do inactive people experience?
Time frame: 2035
Effect of targeted health dialogues on blood metabolites
Do targeted health dialogues affect food-related metabolites in the blood?
Time frame: 2035
Started Oct 2020 (actual). Primary completion is estimated for Dec 2030, 122 months after the start.
Of 52 non-industry observational studies under Health Behavior, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 55. This study's planned 122 months is above that.
Counting every sponsor, half of 54 studies reached it within 22 months; a quarter within 4 and three quarters within 52.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.